RARE Insider Transactions
Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
---|---|---|---|---|---|---|---|---|
2023-03-01 | Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | 39,400 | A-Award | A | 39,400 | 45.65 | 1,798,610.00 |
2023-03-01 | Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | 56,139 | S-Sale | D | 3,161 | 45.25 | 143,035.25 |
2023-03-01 | Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | 59,101 | A-Award | A | 22,000 | 0.00 | 0.00 |
2023-03-01 | Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | 37,101 | A-Award | A | 2,663 | 0.00 | 0.00 |
2023-03-01 | Bedrosian Camille L | officer: EVP and Chief Medical Officer | 46,720 | S-Sale | D | 3,881 | 45.25 | 175,615.25 |
2023-03-01 | Bedrosian Camille L | officer: EVP and Chief Medical Officer | 50,601 | A-Award | A | 2,663 | 0.00 | 0.00 |
2023-03-01 | Kassberg Thomas Richard | officer: CBO & EVP | 39,400 | A-Award | A | 39,400 | 45.65 | 1,798,610.00 |
2023-03-01 | Kassberg Thomas Richard | officer: CBO & EVP | 246,860 | D-Return | D | 3,394 | 45.65 | 154,936.10 |
2023-03-01 | Kassberg Thomas Richard | officer: CBO & EVP | 250,254 | S-Sale | D | 1,968 | 45.27 | 89,091.36 |
2023-03-01 | Kassberg Thomas Richard | officer: CBO & EVP | 252,222 | A-Award | A | 22,000 | 0.00 | 0.00 |
2023-03-01 | Kassberg Thomas Richard | officer: CBO & EVP | 230,222 | A-Award | A | 2,663 | 0.00 | 0.00 |
2023-03-01 | Harris Erik | officer: EVP & Chief Commercial Officer | 39,400 | A-Award | A | 39,400 | 45.65 | 1,798,610.00 |
2023-03-01 | Harris Erik | officer: EVP & Chief Commercial Officer | 57,344 | S-Sale | D | 3,664 | 45.25 | 165,796.00 |
2023-03-01 | Harris Erik | officer: EVP & Chief Commercial Officer | 60,823 | A-Award | A | 22,000 | 0.00 | 0.00 |
2023-03-01 | Harris Erik | officer: EVP & Chief Commercial Officer | 38,823 | A-Award | A | 2,663 | 0.00 | 0.00 |
2023-03-01 | KAKKIS EMIL D | director, officer: President & CEO | 83,500 | A-Award | A | 83,500 | 45.65 | 3,811,775.00 |
2023-03-01 | KAKKIS EMIL D | director, officer: President & CEO | 599,176 | F-InKind | D | 16,140 | 45.65 | 736,791.00 |
2023-03-01 | KAKKIS EMIL D | director, officer: President & CEO | 615,606 | A-Award | A | 46,200 | 0.00 | 0.00 |
2023-03-01 | KAKKIS EMIL D | director, officer: President & CEO | 569,406 | A-Award | A | 8,716 | 0.00 | 0.00 |
2023-03-01 | Pinion John Richard | officer: EVP, Chief Quality Operations Officer | 39,400 | A-Award | A | 39,400 | 45.65 | 1,798,610.00 |
2023-03-01 | Pinion John Richard | officer: EVP, Chief Quality Operations Officer | 76,160 | D-Return | D | 4,014 | 45.65 | 183,239.10 |
2023-03-01 | Pinion John Richard | officer: EVP, Chief Quality Operations Officer | 80,174 | S-Sale | D | 3,755 | 45.26 | 169,951.30 |
2023-03-01 | Pinion John Richard | officer: EVP, Chief Quality Operations Officer | 83,929 | A-Award | A | 22,000 | 0.00 | 0.00 |
2023-03-01 | Pinion John Richard | officer: EVP, Chief Quality Operations Officer | 61,929 | A-Award | A | 2,663 | 0.00 | 0.00 |
2023-03-01 | Huang Dennis Karl | officer: EVP, Chief Technical Operations Officer | 39,400 | A-Award | A | 39,400 | 45.65 | 1,798,610.00 |
2023-03-01 | Huang Dennis Karl | officer: EVP, Chief Technical Operations Officer | 64,715 | D-Return | D | 10,599 | 45.65 | 483,844.35 |
2023-03-01 | Huang Dennis Karl | officer: EVP, Chief Technical Operations Officer | 75,314 | S-Sale | D | 389 | 45.65 | 17,757.85 |
2023-03-01 | Huang Dennis Karl | officer: EVP, Chief Technical Operations Officer | 75,703 | A-Award | A | 22,000 | 0.00 | 0.00 |
2023-03-01 | Huang Dennis Karl | officer: EVP, Chief Technical Operations Officer | 53,703 | A-Award | A | 2,663 | 0.00 | 0.00 |
2023-03-01 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 10,120 | A-Award | A | 10,120 | 45.65 | 461,978.00 |
2023-03-01 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 21,715 | D-Return | D | 1,333 | 45.65 | 60,851.45 |
2023-03-01 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 23,048 | S-Sale | D | 100 | 45.65 | 4,565.00 |
2023-03-01 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 23,148 | A-Award | A | 7,590 | 0.00 | 0.00 |
2023-02-28 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 15,558 | S-Sale | D | 639 | 43.40 | 27,732.60 |
2022-12-30 | KAKKIS EMIL D | director, officer: President & CEO | 541,108 | S-Sale | D | 19,582 | 45.57 | 892,351.74 |
2022-12-21 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 16,197 | S-Sale | D | 2,031 | 43.96 | 89,282.76 |
2022-10-14 | Dier Mardi | officer: CFO & Executive Vice President | 66,695 | S-Sale | D | 1,629 | 40.16 | 65,420.64 |
2022-10-12 | Dier Mardi | officer: CFO & Executive Vice President | 68,324 | S-Sale | D | 3,484 | 38.22 | 133,158.48 |
2022-09-16 | Dier Mardi | officer: CFO & Executive Vice President | 71,808 | A-Award | A | 20,000 | 0.00 | 0.00 |
2022-09-01 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 18,094 | A-Award | A | 1,000 | 0.00 | 0.00 |
2022-06-24 | Sanders Corazon (Corsee) D. | director | 6,245 | A-Award | A | 6,245 | 60.57 | 378,259.65 |
2022-06-24 | Sanders Corazon (Corsee) D. | director | 7,195 | A-Award | A | 3,300 | 0.00 | 0.00 |
2022-06-24 | WELCH DANIEL G | director | 6,245 | A-Award | A | 6,245 | 60.57 | 378,259.65 |
2022-06-24 | WELCH DANIEL G | director | 17,745 | A-Award | A | 3,300 | 0.00 | 0.00 |
2022-06-24 | Ekman Lars | director | 6,245 | A-Award | A | 6,245 | 60.57 | 378,259.65 |
2022-06-24 | Ekman Lars | director | 17,745 | A-Award | A | 3,300 | 0.00 | 0.00 |
2022-06-24 | Fust Matthew K | director | 6,245 | A-Award | A | 6,245 | 60.57 | 378,259.65 |
2022-06-24 | Fust Matthew K | director | 26,495 | A-Award | A | 3,300 | 0.00 | 0.00 |
2022-06-24 | Ray Amrit | director | 6,245 | A-Award | A | 6,245 | 60.57 | 378,259.65 |
2022-06-24 | Ray Amrit | director | 8,420 | A-Award | A | 3,300 | 0.00 | 0.00 |
2022-06-24 | NARACHI MICHAEL | director | 6,245 | A-Award | A | 6,245 | 60.57 | 378,259.65 |
2022-06-24 | NARACHI MICHAEL | director | 17,745 | A-Award | A | 3,300 | 0.00 | 0.00 |
2022-06-24 | Dunsire Deborah | director | 6,245 | A-Award | A | 6,245 | 60.57 | 378,259.65 |
2022-06-24 | Dunsire Deborah | director | 15,870 | A-Award | A | 3,300 | 0.00 | 0.00 |
2022-06-24 | SULIMAN SHEHNAAZ | director | 6,245 | A-Award | A | 6,245 | 60.57 | 378,259.65 |
2022-06-24 | SULIMAN SHEHNAAZ | director | 10,995 | A-Award | A | 3,300 | 0.00 | 0.00 |
2022-06-19 | Harris Erik | officer: EVP & Chief Commercial Officer | 36,160 | S-Sale | D | 295 | 54.78 | 16,160.10 |
2022-04-19 | Ray Amrit | director | 9,525 | A-Award | A | 9,525 | 78.10 | 743,902.50 |
2022-04-19 | Ray Amrit | director | 5,120 | A-Award | A | 5,120 | 0.00 | 0.00 |
2022-04-16 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 16,914 | S-Sale | D | 132 | 84.55 | 11,160.60 |
2022-03-11 | Kassberg Thomas Richard | officer: CBO & EVP | 227,559 | S-Sale | D | 10,281 | 67.01 | 688,929.81 |
2022-03-07 | Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | 34,438 | S-Sale | D | 5,140 | 62.95 | 323,563.00 |
2022-03-04 | Fust Matthew K | director | 0 | M-Exempt | D | 7,500 | 40.37 | 302,775.00 |
2022-03-04 | Fust Matthew K | director | 23,195 | M-Exempt | A | 7,500 | 40.37 | 302,775.00 |
2022-03-03 | Dier Mardi | officer: CFO & Executive Vice President | 24,900 | A-Award | D | 24,900 | 67.37 | 1,677,513.00 |
2022-03-03 | Dier Mardi | officer: CFO & Executive Vice President | 51,808 | S-Sale | D | 420 | 64.55 | 27,111.00 |
2022-03-01 | KAKKIS EMIL D | director, officer: President & CEO | 92,360 | A-Award | A | 92,360 | 67.37 | 6,222,293.20 |
2022-03-01 | KAKKIS EMIL D | director, officer: President & CEO | 634,226 | A-Award | A | 52,041 | 0.00 | 0.00 |
2022-03-01 | KAKKIS EMIL D | director, officer: President & CEO | 582,185 | F-InKind | D | 12,162 | 67.37 | 819,353.94 |
2022-03-01 | Bedrosian Camille L | officer: EVP and Chief Medical Officer | 24,900 | A-Award | A | 24,900 | 67.37 | 1,677,513.00 |
2022-03-01 | Bedrosian Camille L | officer: EVP and Chief Medical Officer | 47,938 | A-Award | A | 14,000 | 0.00 | 0.00 |
2022-03-01 | Bedrosian Camille L | officer: EVP and Chief Medical Officer | 33,938 | S-Sale | D | 2,821 | 66.62 | 187,935.02 |
2022-03-01 | Kassberg Thomas Richard | officer: CBO & EVP | 24,900 | A-Award | A | 24,900 | 67.37 | 1,677,513.00 |
2022-03-01 | Kassberg Thomas Richard | officer: CBO & EVP | 227,840 | A-Award | A | 14,000 | 0.00 | 0.00 |
2022-03-01 | Kassberg Thomas Richard | officer: CBO & EVP | 213,840 | S-Sale | D | 2,374 | 66.62 | 158,155.88 |
2022-03-01 | Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | 24,900 | A-Award | A | 24,900 | 67.37 | 1,677,513.00 |
2022-03-01 | Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | 39,578 | A-Award | A | 14,000 | 0.00 | 0.00 |
2022-03-01 | Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | 25,472 | S-Sale | D | 2,886 | 66.62 | 192,265.32 |
2022-03-01 | Huang Dennis Karl | officer: EVP, Chief Technical Operations Officer and Gene Therapy Operations | 24,900 | A-Award | A | 24,900 | 67.37 | 1,677,513.00 |
2022-03-01 | Huang Dennis Karl | officer: EVP, Chief Technical Operations Officer and Gene Therapy Operations | 51,040 | A-Award | A | 14,000 | 0.00 | 0.00 |
2022-03-01 | Huang Dennis Karl | officer: EVP, Chief Technical Operations Officer and Gene Therapy Operations | 36,914 | S-Sale | D | 3,234 | 66.62 | 215,449.08 |
2022-03-01 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 7,400 | A-Award | A | 7,400 | 67.37 | 498,538.00 |
2022-03-01 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 17,046 | A-Award | A | 3,710 | 0.00 | 0.00 |
2022-03-01 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 13,229 | S-Sale | D | 843 | 66.62 | 56,160.66 |
2022-03-01 | Pinion John Richard | officer: EVP of Translational Sciences and Chief Quality Officer | 24,900 | A-Award | A | 24,900 | 67.37 | 1,677,513.00 |
2022-03-01 | Pinion John Richard | officer: EVP of Translational Sciences and Chief Quality Officer | 59,266 | A-Award | A | 14,000 | 0.00 | 0.00 |
2022-03-01 | Pinion John Richard | officer: EVP of Translational Sciences and Chief Quality Officer | 45,266 | S-Sale | D | 4,498 | 66.62 | 299,656.76 |
2022-03-01 | Harris Erik | officer: EVP & Chief Commercial Officer | 24,900 | A-Award | A | 24,900 | 67.37 | 1,677,513.00 |
2022-03-01 | Harris Erik | officer: EVP & Chief Commercial Officer | 36,317 | A-Award | A | 14,000 | 0.00 | 0.00 |
2022-03-01 | Harris Erik | officer: EVP & Chief Commercial Officer | 22,317 | S-Sale | D | 2,713 | 66.62 | 180,740.06 |
2022-03-01 | Dier Mardi | officer: CFO & Executive Vice President | 52,228 | A-Award | A | 14,000 | 0.00 | 0.00 |
2022-03-01 | Dier Mardi | officer: CFO & Executive Vice President | 38,228 | S-Sale | D | 534 | 66.62 | 35,575.08 |
2022-01-30 | Bedrosian Camille L | officer: EVP and Chief Medical Officer | 36,759 | S-Sale | D | 1,657 | 66.30 | 109,859.10 |
2021-12-10 | KAKKIS EMIL D | director, officer: President & CEO | 2,209,741 | G-Gift | D | 50,000 | 0.00 | 0.00 |
2021-12-10 | Kassberg Thomas Richard | officer: CBO & EVP | 216,214 | G-Gift | D | 52 | 0.00 | 0.00 |
2021-10-14 | Dier Mardi | officer: CFO & Executive Vice President | 38,762 | S-Sale | D | 3,261 | 81.16 | 264,662.76 |
2021-10-14 | Kassberg Thomas Richard | officer: CBO & EVP | 216,266 | S-Sale | D | 286 | 81.14 | 23,206.04 |
2021-10-14 | Bedrosian Camille L | officer: EVP and Chief Medical Officer | 38,416 | S-Sale | D | 359 | 81.14 | 29,129.26 |
2021-10-14 | Harris Erik | officer: EVP & Chief Commercial Officer | 25,030 | S-Sale | D | 303 | 81.14 | 24,585.42 |
2021-10-14 | Huang Dennis Karl | officer: EVP & Chief Tech Ops Officer | 40,148 | S-Sale | D | 358 | 81.14 | 29,048.12 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.